Clinical Trial Update: Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of paclitaxel, carboplatin, and topotecan in patients with ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Hycamtin (Topotecan)
• Paraplatin (Carboplatin)
• Taxol (paclitaxel)

Snippet

Sponsor: AGO Study Group | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED